Tuttle Tactical Management purchased a new position in Danaher Co. (NYSE:DHR) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 17,812 shares of the conglomerate’s stock, valued at approximately $2,352,000.
A number of other large investors have also bought and sold shares of the stock. HL Financial Services LLC boosted its stake in Danaher by 0.4% in the first quarter. HL Financial Services LLC now owns 19,148 shares of the conglomerate’s stock valued at $2,528,000 after acquiring an additional 79 shares during the last quarter. Cornerstone Advisors Inc. boosted its position in shares of Danaher by 2.9% during the first quarter. Cornerstone Advisors Inc. now owns 2,783 shares of the conglomerate’s stock worth $367,000 after purchasing an additional 79 shares in the last quarter. First Personal Financial Services boosted its position in shares of Danaher by 13.7% during the first quarter. First Personal Financial Services now owns 664 shares of the conglomerate’s stock worth $88,000 after purchasing an additional 80 shares in the last quarter. Carroll Financial Associates Inc. boosted its position in shares of Danaher by 5.6% during the first quarter. Carroll Financial Associates Inc. now owns 1,534 shares of the conglomerate’s stock worth $202,000 after purchasing an additional 82 shares in the last quarter. Finally, Cookson Peirce & Co. Inc. boosted its position in shares of Danaher by 1.8% during the first quarter. Cookson Peirce & Co. Inc. now owns 4,710 shares of the conglomerate’s stock worth $622,000 after purchasing an additional 83 shares in the last quarter. 78.82% of the stock is owned by hedge funds and other institutional investors.
In other Danaher news, Director Alan G. Spoon sold 1,913 shares of the firm’s stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $129.52, for a total value of $247,771.76. Following the transaction, the director now directly owns 86,863 shares of the company’s stock, valued at $11,250,495.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Matthew Mcgrew sold 22,738 shares of the stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $130.89, for a total transaction of $2,976,176.82. Following the completion of the sale, the chief financial officer now owns 27,534 shares of the company’s stock, valued at approximately $3,603,925.26. The disclosure for this sale can be found here. Over the last three months, insiders have sold 453,448 shares of company stock worth $59,724,640. 11.40% of the stock is owned by insiders.
Shares of NYSE:DHR traded down $1.29 during midday trading on Wednesday, hitting $140.91. The stock had a trading volume of 2,268,135 shares, compared to its average volume of 2,698,432. The stock has a 50-day moving average price of $135.18. The company has a market capitalization of $100.87 billion, a P/E ratio of 31.17, a P/E/G ratio of 2.74 and a beta of 0.95. Danaher Co. has a fifty-two week low of $94.59 and a fifty-two week high of $144.57. The company has a quick ratio of 1.74, a current ratio of 2.18 and a debt-to-equity ratio of 0.32.
Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, April 18th. The conglomerate reported $1.07 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.06. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The business had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.80 billion. During the same period in the prior year, the company earned $0.99 EPS. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. As a group, equities research analysts expect that Danaher Co. will post 4.77 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.48%. The ex-dividend date is Thursday, June 27th. Danaher’s dividend payout ratio is presently 15.04%.
A number of equities analysts have recently weighed in on the stock. Zacks Investment Research cut shares of Danaher from a “hold” rating to a “sell” rating in a research report on Tuesday, April 30th. Wolfe Research assumed coverage on shares of Danaher in a report on Thursday, May 30th. They set an “outperform” rating on the stock. Needham & Company LLC restated a “buy” rating and set a $141.00 price objective (up from $138.00) on shares of Danaher in a report on Wednesday, April 17th. Piper Jaffray Companies began coverage on shares of Danaher in a report on Tuesday, June 11th. They set a “neutral” rating and a $148.00 price objective on the stock. Finally, Jefferies Financial Group lifted their price target on shares of Danaher to $140.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Three investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $133.00.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: Capital Gains
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.